Fiera Capital Corp Has $49.46 Million Stake in Danaher Co. (NYSE:DHR)

Fiera Capital Corp lowered its position in Danaher Co. (NYSE:DHR) by 8.3% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 177,898 shares of the conglomerate’s stock after selling 16,200 shares during the period. Fiera Capital Corp’s holdings in Danaher were worth $49,459,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in DHR. nVerses Capital LLC acquired a new stake in shares of Danaher in the 2nd quarter valued at $25,000. CarsonAllaria Wealth Management Ltd. acquired a new stake in shares of Danaher in the second quarter worth about $25,000. MFA Wealth Advisors LLC bought a new stake in shares of Danaher during the 2nd quarter worth about $51,000. Financial Connections Group Inc. bought a new position in shares of Danaher in the 2nd quarter valued at approximately $51,000. Finally, Western Pacific Wealth Management LP acquired a new stake in Danaher in the 1st quarter worth approximately $55,000. Institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

NYSE:DHR traded down $0.14 during mid-day trading on Friday, hitting $245.96. The company’s stock had a trading volume of 841,038 shares, compared to its average volume of 2,734,411. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The stock has a fifty day moving average of $265.79 and a 200-day moving average of $260.75. The company has a market capitalization of $177.65 billion, a price-to-earnings ratio of 46.97, a P/E/G ratio of 4.54 and a beta of 0.85. Danaher Co. has a fifty-two week low of $192.35 and a fifty-two week high of $281.70.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. The company had revenue of $5.80 billion during the quarter, compared to analysts’ expectations of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. During the same period last year, the business earned $2.02 earnings per share. The business’s revenue was up 3.1% on a year-over-year basis. As a group, equities analysts forecast that Danaher Co. will post 7.51 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were paid a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.44%. The ex-dividend date of this dividend was Friday, September 27th. Danaher’s dividend payout ratio (DPR) is currently 20.61%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the stock. UBS Group dropped their price target on shares of Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a research report on Wednesday, October 23rd. Stephens reissued an “overweight” rating and set a $315.00 target price on shares of Danaher in a research report on Wednesday, October 23rd. StockNews.com upgraded shares of Danaher from a “hold” rating to a “buy” rating in a report on Wednesday. Wolfe Research raised Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price objective for the company in a research report on Thursday, October 31st. Finally, Leerink Partners raised their target price on Danaher from $275.00 to $280.00 and gave the company an “outperform” rating in a report on Wednesday, July 24th. Five equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, Danaher presently has a consensus rating of “Moderate Buy” and an average target price of $287.16.

Insider Transactions at Danaher

In other Danaher news, SVP Georgeann Couchara sold 952 shares of Danaher stock in a transaction on Monday, August 26th. The stock was sold at an average price of $268.37, for a total value of $255,488.24. Following the completion of the transaction, the senior vice president now owns 4,212 shares in the company, valued at approximately $1,130,374.44. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 10.90% of the stock is owned by company insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.